Toxoplasma gondii infection and its implications within the central nervous system

SK Matta, N Rinkenberger, IR Dunay… - Nature Reviews …, 2021 - nature.com
Toxoplasma gondii is a parasite that infects a wide range of animals and causes zoonotic
infections in humans. Although it normally only results in mild illness in healthy individuals …

MicroRNAs: Master regulators in host–parasitic protist interactions

M Rojas-Pirela, D Andrade-Alviárez… - Open …, 2022 - royalsocietypublishing.org
MicroRNAs (miRNAs) are a group of small non-coding RNAs present in a wide diversity of
organisms. MiRNAs regulate gene expression at a post-transcriptional level through their …

The constant threat of zoonotic and vector-borne emerging tropical diseases: living on the edge

AJ Rodriguez-Morales, AE Paniz-Mondolfi… - Frontiers in tropical …, 2021 - frontiersin.org
Emerging diseases have significantly impacted the last few decades (1–10). The emergence
and re-emergence of vector-borne and zoonotic diseases in Africa, Asia, and Latin America …

Genetic diversity of Toxoplasma gondii in South America: occurrence, immunity, and fate of infection

RMM Brito, G de Lima Bessa, AL Bastilho… - Parasites & …, 2023 - Springer
Toxoplasma gondii is an intracellular parasite with a worldwide distribution. Toxoplasma
gondii infections are of great concern for public health, and their impact is usually most …

A potential cure for tumor‐associated immunosuppression by Toxoplasma gondii

N Lotfalizadeh, S Sadr, S Morovati… - Cancer …, 2024 - Wiley Online Library
Background Recently, immunotherapy has become very hopeful for cancer therapy. Cancer
treatment through immunotherapy has excellent specificity and less toxicity than …

ROP16 of Toxoplasma gondii Inhibits Innate Immunity by Triggering cGAS-STING Pathway Inactivity through the Polyubiquitination of STING

QW Jin, T Yu, M Pan, YM Fan, SY Huang - Cells, 2023 - mdpi.com
cGAS-STING signaling is a major pathway in inducing type Ⅰ IFN, which plays a crucial role
in the defense against T. gondii infection. In contrast, T. gondii develops multiple strategies …

Treatment strategy in human ocular toxoplasmosis: Why antibiotics have failed

JG Garweg, U Pleyer - Journal of clinical medicine, 2021 - mdpi.com
Background: There is currently no clear evidence of the effectiveness of antibiotic therapy in
acute ocular toxoplasmosis (OT), but its effect as a secondary prophylaxis is undisputed. The …

scDual-Seq of Toxoplasma gondii-infected mouse BMDCs reveals heterogeneity and differential infection dynamics

F Hildebrandt, M Mohammed, A Dziedziech… - Frontiers in …, 2023 - frontiersin.org
Dendritic cells and macrophages are integral parts of the innate immune system and
gatekeepers against infection. The protozoan pathogen, Toxoplasma gondii, is known to …

Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quindío) Colombia: An observational retrospective analysis

M Mejia-Oquendo, E Marulanda-Ibarra… - The Lancet Regional …, 2021 - thelancet.com
Background Colombia implemented the world's first evidence-based guidelines for
congenital toxoplasmosis in 2013, no evaluation of its impact has been reported. Methods …

Genetic Variations in the Purinergic P2X7 Receptor Are Associated with the Immune Response to Ocular Toxoplasmosis in Colombia

CA Naranjo-Galvis, R McLeod, JE Gómez-Marín… - Microorganisms, 2023 - mdpi.com
Ocular toxoplasmosis (OT) is characterized by inflammation within the eye and is the most
recognized clinical manifestation of toxoplasmosis. The objective of this study was to identify …